118 related articles for article (PubMed ID: 26666224)
1. Quantitative proteomics signature profiling based on network contextualization.
Bin Goh WW; Guo T; Aebersold R; Wong L
Biol Direct; 2015 Dec; 10():71. PubMed ID: 26666224
[TBL] [Abstract][Full Text] [Related]
2. Fuzzy-FishNET: a highly reproducible protein complex-based approach for feature selection in comparative proteomics.
Goh WW
BMC Med Genomics; 2016 Dec; 9(Suppl 3):67. PubMed ID: 28117654
[TBL] [Abstract][Full Text] [Related]
3. Proteomic investigation of intra-tumor heterogeneity using network-based contextualization - A case study on prostate cancer.
Goh WWB; Zhao Y; Sue AC; Guo T; Wong L
J Proteomics; 2019 Aug; 206():103446. PubMed ID: 31323421
[TBL] [Abstract][Full Text] [Related]
4. Proteomics signature profiling (PSP): a novel contextualization approach for cancer proteomics.
Goh WW; Lee YH; Ramdzan ZM; Sergot MJ; Chung M; Wong L
J Proteome Res; 2012 Mar; 11(3):1571-81. PubMed ID: 22243476
[TBL] [Abstract][Full Text] [Related]
5. Evaluating feature-selection stability in next-generation proteomics.
Goh WW; Wong L
J Bioinform Comput Biol; 2016 Oct; 14(5):1650029. PubMed ID: 27640811
[TBL] [Abstract][Full Text] [Related]
6. Advancing Clinical Proteomics via Analysis Based on Biological Complexes: A Tale of Five Paradigms.
Goh WW; Wong L
J Proteome Res; 2016 Sep; 15(9):3167-79. PubMed ID: 27454466
[TBL] [Abstract][Full Text] [Related]
7. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
[TBL] [Abstract][Full Text] [Related]
8. Integrated microRNA, mRNA, and protein expression profiling reveals microRNA regulatory networks in rat kidney treated with a carcinogenic dose of aristolochic acid.
Li Z; Qin T; Wang K; Hackenberg M; Yan J; Gao Y; Yu LR; Shi L; Su Z; Chen T
BMC Genomics; 2015 May; 16(1):365. PubMed ID: 25952319
[TBL] [Abstract][Full Text] [Related]
9. Pathway analysis of kidney cancer using proteomics and metabolic profiling.
Perroud B; Lee J; Valkova N; Dhirapong A; Lin PY; Fiehn O; Kültz D; Weiss RH
Mol Cancer; 2006 Nov; 5():64. PubMed ID: 17123452
[TBL] [Abstract][Full Text] [Related]
10. Protein complex-based analysis is resistant to the obfuscating consequences of batch effects --- a case study in clinical proteomics.
Goh WW; Wong L
BMC Genomics; 2017 Mar; 18(Suppl 2):142. PubMed ID: 28361693
[TBL] [Abstract][Full Text] [Related]
11. Biological network module-based model for the analysis of differential expression in shotgun proteomics.
Xu J; Wang L; Li J
J Proteome Res; 2014 Dec; 13(12):5743-50. PubMed ID: 25327611
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the utility of Proteomics Signature Profiling (PSP) with Pathway Derived Subnets (PDSs), performance analysis and specialised ontologies.
Goh WW; Fan M; Low HS; Sergot M; Wong L
BMC Genomics; 2013 Jan; 14():35. PubMed ID: 23324392
[TBL] [Abstract][Full Text] [Related]
13. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
Merrick BA; Bruno ME
Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
[TBL] [Abstract][Full Text] [Related]
14. Expression profiling of more than 3500 proteins of MSS-type colorectal cancer by stable isotope labeling and mass spectrometry.
Kang UB; Yeom J; Kim HJ; Kim H; Lee C
J Proteomics; 2012 Jun; 75(10):3050-62. PubMed ID: 22154799
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer atlas: An integrative resource for genomic and proteomic annotations from colorectal cancer cell lines and tissues.
Chisanga D; Keerthikumar S; Pathan M; Ariyaratne D; Kalra H; Boukouris S; Mathew NA; Al Saffar H; Gangoda L; Ang CS; Sieber OM; Mariadason JM; Dasgupta R; Chilamkurti N; Mathivanan S
Nucleic Acids Res; 2016 Jan; 44(D1):D969-74. PubMed ID: 26496946
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
[TBL] [Abstract][Full Text] [Related]
17. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z
Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
[TBL] [Abstract][Full Text] [Related]
18. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
[TBL] [Abstract][Full Text] [Related]
19. Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples.
Raimondo F; Morosi L; Chinello C; Perego R; Bianchi C; Albo G; Ferrero S; Rocco F; Magni F; Pitto M
Mol Biosyst; 2012 Apr; 8(4):1007-16. PubMed ID: 22159573
[TBL] [Abstract][Full Text] [Related]
20. Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis.
Latosinska A; Vougas K; Makridakis M; Klein J; Mullen W; Abbas M; Stravodimos K; Katafigiotis I; Merseburger AS; Zoidakis J; Mischak H; Vlahou A; Jankowski V
PLoS One; 2015; 10(9):e0137048. PubMed ID: 26331617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
